MENU
+Compare
ZTS
Stock ticker: NYSE
AS OF
Oct 24 closing price
Price
$145.94
Change
-$0.45 (-0.31%)
Capitalization
64.68B

ZTS ZOETIS Forecast, Technical & Fundamental Analysis

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals... Show more

ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ZTS with price predictions
Oct 24, 2025

ZTS's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for ZTS turned positive on October 14, 2025. Looking at past instances where ZTS's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ZTS's RSI Oscillator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 21, 2025. You may want to consider a long position or call options on ZTS as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ZTS advanced for three days, in of 310 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZTS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ZTS entered a downward trend on October 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.987) is normal, around the industry mean (17.235). P/E Ratio (25.119) is within average values for comparable stocks, (73.350). Projected Growth (PEG Ratio) (2.329) is also within normal values, averaging (2.089). ZTS has a moderately low Dividend Yield (0.013) as compared to the industry average of (0.031). P/S Ratio (6.988) is also within normal values, averaging (47.635).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ZTS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ZTS is expected to report earnings to fall 7.39% to $1.63 per share on November 04

ZOETIS ZTS Stock Earnings Reports
Q3'25
Est.
$1.63
Q2'25
Beat
by $0.14
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.12
The last earnings report on August 05 showed earnings per share of $1.76, beating the estimate of $1.62. With 1.38M shares outstanding, the current market capitalization sits at 64.68B.
A.I.Advisor
published Dividends

ZTS is expected to pay dividends on December 02, 2025

ZOETIS ZTS Stock Dividends
A dividend of $0.50 per share will be paid with a record date of December 02, 2025, and an ex-dividend date of October 31, 2025. The last dividend of $0.50 was paid on September 03. Read more...
A.I. Advisor
published General Information

General Information

a pet medication company

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
10 Sylvan Way
Phone
+1 973 822-7000
Employees
14100
Web
https://www.zoetis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CRPT22.211.07
+5.06%
First Trust SkyBdg Cry Idt & Dgt Eco ETF
FNDE36.900.17
+0.46%
Schwab Fundamental Emerging MarketsEqETF
FIIG21.350.03
+0.16%
First Trust Intermediate DurInvGrdCrpETF
CGUI25.360.02
+0.06%
Capital Group Ultra Short Income ETF
TSL18.08-0.81
-4.29%
GraniteShares 1.25x Long Tsla Daily ETF

ZTS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with ELAN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-0.31%
ELAN - ZTS
49%
Loosely correlated
+1.29%
VTRS - ZTS
48%
Loosely correlated
+0.39%
PAHC - ZTS
41%
Loosely correlated
+3.12%
AMRX - ZTS
39%
Loosely correlated
+1.25%
HLN - ZTS
38%
Loosely correlated
-1.28%
More

Groups containing ZTS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-0.31%
Pharmaceuticals: Generic
industry (216 stocks)
39%
Loosely correlated
+0.53%